“An In-Silico and In-Vitro Study of Imatinib and Naringin Combination for Inhibiting P-Glycoprotein and Delaying Drug Resistance in Chronic Myeloid Leukemia”, AJP, vol. 17, no. 2, Jun. 2023, doi: 10.22377/ajp.v17i2.4859.